1.79
+0.02(+1.13%)
Currency In USD
| Previous Close | 1.77 |
| Open | 1.75 |
| Day High | 1.84 |
| Day Low | 1.73 |
| 52-Week High | 3.29 |
| 52-Week Low | 1.66 |
| Volume | 781,257 |
| Average Volume | 452,068 |
| Market Cap | 151.67M |
| PE | -5.97 |
| EPS | -0.3 |
| Moving Average 50 Days | 2.21 |
| Moving Average 200 Days | 2.07 |
| Change | 0.02 |
If you invested $1000 in Stereotaxis, Inc. (STXS) 10 years ago, it would be worth $848.34 as of March 12, 2025 at a share price of $1.79. Whereas If you bought $1000 worth of Stereotaxis, Inc. (STXS) shares 5 years ago, it would be worth $637.01 as of March 12, 2025 at a share price of $1.79.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Stereotaxis to Present at 37th Annual Roth Conference
GlobeNewswire Inc.
Mar 10, 2025 12:02 PM GMT
ST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the
Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery
GlobeNewswire Inc.
Mar 03, 2025 12:32 PM GMT
ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA regulatory submission for the first robotically navigated
Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance
GlobeNewswire Inc.
Mar 03, 2025 12:31 PM GMT
ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA regulatory submission for the MAGiC Sweep™ catheter. MAGi